For an average adult female without significant comorbidities, is an abdominal hysterectomy with bilateral salpingo‑oophorectomy and staging classified as high‑risk or intermediate‑risk surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surgical Risk Classification

An abdominal hysterectomy with bilateral salpingo-oophorectomy and staging is classified as intermediate-risk surgery for an average adult female without significant comorbidities.

Rationale for Risk Classification

The surgical risk stratification is based on the procedural complexity, expected operative time, and physiologic stress imposed on the patient. This procedure involves:

  • Intra-abdominal access via laparotomy, which requires general anesthesia and creates moderate physiologic stress 1
  • Multiple organ system manipulation including removal of the uterus, both ovaries, and fallopian tubes 1
  • Staging procedures that extend operative time and include peritoneal biopsies, omentectomy, and potential lymph node sampling 1

Factors Supporting Intermediate-Risk Classification

Operative Complexity

  • The procedure requires median laparotomy with thorough abdominal cavity examination 1
  • Staging components include peritoneal washings, random peritoneal biopsies of the paracolic gutters and pelvic peritoneum, infracolic omentectomy, and pelvic/para-aortic lymph node sampling 1
  • These additional staging procedures increase operative time beyond a simple hysterectomy 2

Expected Outcomes in Average-Risk Patients

  • When performed by appropriately trained gynecologic oncologists, the procedure has well-established safety profiles 1
  • Minimally invasive approaches (when feasible) demonstrate lower complication rates compared to open procedures, with major complication rates of 6.4% for robotic surgery versus 20% for laparotomy 1
  • The abdominal approach is specifically utilized for suspected malignancy or when extensive staging is required 2

Comparison to High-Risk Procedures

This procedure does not meet criteria for high-risk surgery because:

  • It does not involve extensive cytoreductive efforts with resection of bowel, diaphragm, or other organs 1
  • The patient lacks significant comorbidities that would elevate surgical risk 1
  • Standard staging procedures are well-tolerated in appropriately selected patients 1

Important Clinical Caveats

Age-Related Considerations

  • Premenopausal women (particularly those under age 45) undergoing bilateral salpingo-oophorectomy face increased long-term all-cause mortality risk (hazard ratio 1.15 for ages 35-44) 3
  • This mortality risk attenuates with increasing age at surgery, with procedures after age 45 showing decreased mortality rates 3
  • Women under age 35 undergoing hysterectomy alone also demonstrate increased mortality (hazard ratio 1.29) 3

Ovarian Preservation Decisions

  • For women under 45 years with less than 50% myometrial invasion and no family history of ovarian cancer risk, ovarian preservation should be considered 1
  • Bilateral salpingo-oophorectomy in premenopausal women without malignancy is associated with increased cardiovascular disease risk and all-cause mortality 4, 5
  • Approximately 40% of bilateral salpingo-oophorectomies performed at benign hysterectomy have no documented indication 5

Surgeon Experience Requirements

  • Surgery should be performed by an appropriately trained gynecologic oncologist with experience in ovarian cancer management when staging is indicated 1
  • Significant between-surgeon variation exists in practice patterns, even after adjusting for patient case mix 5

Postoperative Hormone Considerations

  • Women experiencing premature menopause due to bilateral oophorectomy should be counseled about hormone replacement therapy 6
  • For early-stage endometrial cancer (stage I-II), estrogen replacement is reasonable for low-risk patients 6
  • Women with endometriosis history require combined estrogen/progestogen therapy rather than estrogen alone 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hysterectomy and Bilateral Salpingectomy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.

American journal of obstetrics and gynecology, 2020

Guideline

Hormone Replacement Therapy After Total Hysterectomy and Bilateral Salpingo-Oophorectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.